Trefoil Peptides in Lung Diseases

Completed

• Conditions: Chronic Obstructive Pulmonary Disease; Asthma

• Registration Number: NCT00839735
• Lead Sponsor: Bispebjerg Hospital

Brief Summary

The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02
• Study First Submitted: 2009-02-06
• Study First Submitted QC: 2009-02-06
• Study First Posted: 2009-02-09
• Primary Completion: 2010-05
• Study Completion: 2010-05
• Status Verified: 2021-02
• Last Update Submitted: 2021-02-14
• Last Update Posted: 2021-02-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Age 18 years or older
• Informed consent

Exclusion Criteria

• Upper and lower airway infection 2 weeks prior to visit 1

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TFF in sputum	Monthly

Trial Locations

Locations (1)

Respiratory and Allergy Research Unit, Department of Respiratory Medicine L, Bispebjerg Hospital; 🇩🇰 Copenhagen, Denmark